Krajewski Eduardo, Soriano Ian S, Ortiz Jorge
Department of Surgery, Albert Einstein Medical Center, Philadelphia, Pennsylvania 19141, USA.
JSLS. 2006 Oct-Dec;10(4):426-31.
Solid-organ transplantation has become the treatment of choice for patients with end-stage renal disease, end-stage liver failure, and some patients with type 1 diabetes mellitus. Similarly, surgical expertise and mechanical improvements have led to significant advances in laparoscopic surgery. Laparoscopic interventions are sometimes not pursued in transplant recipients due to the lack of strong supporting evidence for the use of laparoscopic techniques in these patients.
Using an extensive literature search, we review herein the available data on the utility of laparoscopic interventions in transplant recipients, with particular attention to the risks and benefits, indications, and contraindications for this complex patient population.
Although randomized trials are few, multiple case reports indicate that many transplant recipients have benefited from laparoscopic interventions.
The well-known benefits of laparoscopy could be extended to transplant recipients.
实体器官移植已成为终末期肾病、终末期肝衰竭以及部分1型糖尿病患者的首选治疗方法。同样,手术专业技术和器械改进推动了腹腔镜手术的显著进展。由于缺乏在这些患者中使用腹腔镜技术的有力支持证据,移植受者有时不采用腹腔镜干预措施。
通过广泛的文献检索,我们在此回顾了有关腹腔镜干预在移植受者中的效用的现有数据,特别关注这一复杂患者群体的风险与益处、适应证和禁忌证。
尽管随机试验较少,但多篇病例报告表明,许多移植受者已从腹腔镜干预中获益。
腹腔镜检查的诸多已知益处可扩展至移植受者。